Samsara Luggage (SAML) 10-Q 23 May 22 2022 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 23, 2022
Document Information Line Items
Entity Registrant Name	SAMSARA LUGGAGE, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		2,152,945
Amendment Flag	false
Entity Central Index Key	0001530163
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-54649
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-0299456
Entity Address, Address Line One	135 E. 57th Street,
Entity Address, Address Line Two	Suite 18-130
Entity Address, State or Province	NY
Entity Address, City or Town	New York
Entity Address, Postal Zip Code	10022
City Area Code	(855)
Local Phone Number	-256-7477
Entity Interactive Data Current	Yes

Condensed Balance Sheets

Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 349	$ 827
Inventory	188	94
Other current assets	61	53
Total current assets	598	974
Non-current assets
Property and equipment, net	3	3
Total assets	601	977
Current liabilities
Accounts payable	55	74
Other current liabilities	54	131
Related party payable	136	147
Deferred revenue	26	26
Convertible notes and short-term loans	460	256
Conversion option derivative liability	611	1,017
Warrant derivative liability	14	24
Total current liabilities	1,356	1,675
Total liabilities	1,356	1,675
Stockholders’ Deficit
Common stock, $0.0001 par value; 7,500,000,000 shares authorized; 2,152,945 and 2,055,487 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively.
Additional paid-in capital	9,908	9,852
Services receivable	(180)	(356)
Accumulated deficit	(10,483)	(10,194)
Total stockholders’ deficit	(755)	(698)
Total Liabilities and Stockholders’ Deficit	$ 601	$ 977

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, shares authorized	7,500,000,000	7,500,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued	2,152,945	2,055,487
Common stock, shares outstanding	2,152,945	2,055,487

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
REVENUE	$ 31	$ 75
COST OF GOODS SOLD	20	37
GROSS PROFIT	11	38
OPERATING EXPENSES
Research and development	40
Sales and marketing	246	61
General and administrative	168	265
TOTAL OPERATING EXPENSES	454	326
OPERATING LOSS	(443)	(288)
FINANCING INCOME (EXPENSES)
Interest expense	(208)	(72)
Income (expenses) in respect of warrants issued and convertible component in convertible loan, net interest expenses	362	(275)
TOTAL FINANCING INCOME (EXPENSES)	154	(347)
NET LOSS	$ (289)	$ (635)
Per-share data
Basic and diluted loss per share (in Dollars per share)	$ (0.14)	$ (0.76)
Weighted average number of common shares outstanding (in Shares)	2,089,056	841,003

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Services receivable	Accumulated Deficit	Total
Balance at Dec. 31, 2020		$ 6,463	$ (999)	$ (6,376)	$ (912)
Balance (in Shares) at Dec. 31, 2020	786,700
Conversion of convertible debt into common shares		308			308
Conversion of convertible debt into common shares (in Shares)	62,464
Amortization of services			159		159
Net loss				(635)	(635)
Balance at Mar. 31, 2021		6,771	(840)	(7,011)	(1,080)
Balance (in Shares) at Mar. 31, 2021	849,164
Balance at Dec. 31, 2021		9,852	(356)	(10,194)	(698)
Balance (in Shares) at Dec. 31, 2021	2,055,487
Conversion of convertible debt into common shares		56			56
Conversion of convertible debt into common shares (in Shares)	97,458
Amortization of services			176		176
Net loss				(289)	(289)
Balance at Mar. 31, 2022		$ 9,908	$ (180)	$ (10,483)	$ (755)
Balance (in Shares) at Mar. 31, 2022	2,152,945

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows From Operating Activities
Net loss	$ (289)	$ (635)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization of services receivable	176	159
Interest on convertible note and short-term loan and amortization of issuance cost	208	74
Expenses in respect of warrants issued and convertible component in convertible loan, net interest expenses	(364)	275
Change in operating assets and liabilities
Inventory	(94)	18
Other current assets	(8)
Accounts payable	(19)	25
Other current liabilities	(77)
Related parties payable	(11)	38
Net cash provided by (used) in operating activities	(478)	(46)
Cash Flows From Investing Activities
Cash Flows From Financing Activities
Net change in cash and cash equivalents	(478)	(46)
Cash and cash equivalents, beginning of period	827	54
Cash and cash equivalents, end of period	349	8
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income tax
Non-cash investing and financing activities
Common stock issued for conversion of convertible note and accrued interest	56	288
Common stock issued against accounts payables		$ 20

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2022
Organization and Description of Business [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS A. The Company was incorporated on May 7, 2007 under the name, “Darkstar Ventures, Inc.” under the laws of the State of Nevada. The Company is a global smart luggage and smart travel brand. Samsara Luggage unveiled its Next Generation smart carry-on at the 2020 Consumer Electronics Show (CES). The Next Generation is the first to market a Wi-Fi Hotspot technology for travelers to access a secured network globally. Samsara Luggage also launched Essentials by Samsara, a safety kit providing commuters with a new layer of safety with protective items like facemasks, hand sanitizer, disposable gloves and alcohol wipes. These kits are sold individually and gifted to customers with purchase of the Carry-on Aluminum suitcase or Smart Weekender bag. During the last quarter of 2020, Samsara launched Sarah & Sam Fashion and Lifestyle Collection. Sarah& Sam is a part of Samsara Direct business model prompted by the travel limitations due to the coronavirus pandemic, leveraging the company’s established digital assets and manufacturing and fulfillment supply chain capabilities to offer additional consumer products that respond to the changing needs of the market. On November 12, 2019, the Company completed its merger with the Delaware corporation that was previously known as “Samsara Luggage, Inc.” (“Samsara Delaware”) in accordance with the terms of the Merger Agreement and Plan of Merger, dated as of May 10, 2019, (the “Merger Agreement”) by and among the Company, Samsara Delaware, and Avraham Bengio, pursuant to which Samsara Delaware merged with and into the Company, with the Company being the surviving corporation (the “Merger”). Following the completion of the Merger, the business of the Company going forward became the business of Samsara Delaware prior to the Merger, namely, designing, manufacturing, and selling high quality luggage products to meet the evolving needs of frequent travelers and also seeking to present new technologies within the aluminum luggage industry, including an aluminum “smart” suitcase. The Common Stock listed on the OTC Pink Marketplace, previously trading through the close of business on November 11, 2019 under the ticker symbol “DAVC,” commenced trading on the OTC Pink Marketplace under the ticker symbol “SAML” on November 12, 2019. The Common Stock has a new CUSIP number, 79589J101. B. Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of March 31, 2022, the Company had approximately $349 in cash and cash equivalents, approximately $758 in deficit of working capital, a stockholders’ deficiency of approximately $755 and an accumulated deficit of approximately $10,483. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. Management anticipates their business will require substantial additional investments that have not yet been secured. Management is continuing in the process of fund raising in the private equity and capital markets as the Company will need to finance future activities. These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION Unaudited Interim Financial Statements The accompanying unaudited financial statements include the accounts of the Company, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the for three-months ended March 31, 2022. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2022. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates. Certain information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). The accompanying unaudited condensed financial statements should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on April 11, 2022 (the “Annual Report”). For further information, reference is made to the financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“‘US GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to the financial statements, the most significant estimates and assumptions relate to the measurement of the convertible notes and Going Concern. Derivative Liabilities and Fair Value of Financial Instruments Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt under ASC 470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815. Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Fair value of certain of the Company’s financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments. Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk. Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values. Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income. The Company records a debt discount related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the fair value of the conversion features. The debt discount will be accreted by recording additional non-cash gains and losses related to the change in fair values of derivative liabilities over the life of the convertible notes. The Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows: Balance as of March 31, 2022 Level 1 Level 2 Level 3 Total (U.S. dollars in thousands) Liabilities: Fair Value of convertible component in convertible loan, net of discounts and debt issue costs - - 611 611 Fair value of warrants issued in convertible loan - - 14 14 Total liabilities - - 625 625 Balance as of December 31, 2021 Level 1 Level 2 Level 3 Total (U.S. dollars in thousands) Liabilities: Fair Value of convertible component in convertible loan, net of discounts and debt issue costs - - 1,017 1,017 Fair value of warrants issued in convertible loan - - 24 24 Total liabilities - - 1,041 1,041 Reclassification Certain comparative figures have been reclassified to conform to current period presentation. Recent accounting pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

Convertible Notes

Convertible Notes	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE NOTES	NOTE 3 – CONVERTIBLE NOTES A. On June 5, 2019, the Company entered into a Securities Purchase Agreement (“SPA”) with YAII PN, Ltd. (the “Investor”), pursuant to which the Investor agreed to provide the Company with a convertible loan in the aggregate amount of $1,100,000 in three tranches, and the Company agreed to issue convertible debentures and a warrant to the Investor. The first tranche of the convertible debentures in the amount of $200,000 was provided upon execution of the SPA. The second tranche in the amount of $300,000 was provided on October 23, 2019 upon the Company filing of a Registration Statement on Form S-4 in connection with the Merger with Samsara Delaware. The third tranche in the amount of $600,000 was provided on November 18, 2019 upon consummation of the Merger with Samsara Delaware and the fulfillment of all conditions required for the Merger. The Company incurred issuance cost of $100,000 with connection to those convertible debentures. In the period from loan inception through December 31, 2021, the full amount of outstanding principal and accrued interest was converted into shares of common stock. In addition, the Company issued to the Investor a warrant to purchase 13,095 shares of common stock, at an exercise price equal to $21.00. The warrants may be exercised within 5 years from the issuance date by cash payment or through cashless exercise by the surrender of warrants shares having a value equal to the exercise price of the portion of the warrant being exercised. The Company considered the provisions of ASC 815-40, “Derivatives and Hedging: Contracts in Entity’s Own Equity”, with respect to the detachable warrants that were issued to the convertible loan, and determined that as a result of the “cashless exercise” and variable exercise price that would adjust the number of warrants and the exercise price of the warrants based on the price at which the Company subsequently issues shares or other equity-linked financial instruments, such warrants cannot be considered as indexed to the Company’s own stock. Accordingly, the warrants were recognized as derivative liability at their fair value on initial recognition. In subsequent periods, the warrants were marked to market with the changes in fair value recognized as financing expense or income in the consolidated statement of operations. The warrants were estimated by third party appraiser using the Black-Scholes option-pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The following are the data and assumptions used as of the balance sheet dates: March 31, Common stock price $ 0.6 Expected volatility 270.18 % Expected term 2.18 years Risk free rate 2.31 % Expected dividend yield 0 % Fair Market Value of Warrants $ 6 December 31, Common stock price 0.9585 Expected volatility 275.94 % Expected term 2.43 years Risk free rate 0.83 % Expected dividend yield 0 % Fair Market Value of Warrants $ 10 B. On September 3, 2020, Samsara Luggage, Inc. (the “Company”) entered into a second Securities Purchase Agreement (“SPA”) with the Investor, pursuant to which the Investor will invest an aggregate amount of $220 in two tranches, and the Company will issue convertible debentures and warrants to the Investor. The first tranche of the convertible debentures in the amount of $150 was provided upon execution of the SPA. The second tranche in the amount of $70 was provided on October 7, 2020. Each tranche of the loan bears interest at an annual rate of ten percent (10%). Each tranche of the investment bears interest at an annual rate of ten percent (10%) and will be repayable after two years. Each tranche of the investment will be convertible at any time into shares of the Company’s Common Stock at a conversion price equal to the lower of (a) $0.003 per share, or (b) 80% of the lowest the daily dollar volume-weighted average price for the Company’s Common Stock during the 10 trading days immediately preceding the conversion date. In the period from loan inception through December 31, 2021, the full amount of outstanding principal and accrued interest was converted into shares of common stock. In addition, the Company issued to the Investor a warrant to purchase 2,619 shares of common stock, at an exercise price equal to $21.00. The warrants may be exercised within 5 years from the issuance date by cash payment or through cashless exercise by the surrender of warrants shares having a value equal to the exercise price of the portion of the warrant being exercised. The Company considered the provisions of ASC 815-40, “Derivatives and Hedging: Contracts in Entity’s Own Equity”, with respect to the detachable warrants that were issued to the Convertible loan, and determined that as a result of the “cashless exercise” and variable exercise price that would adjust the number of warrants and the exercise price of the warrants based on the price at which the Company subsequently issues shares or other equity-linked financial instruments, such warrants cannot be considered as indexed to the Company’s own stock. Accordingly, the warrants were recognized as derivative liability at their fair value on initial recognition. In subsequent periods, the warrants were marked to market with the changes in fair value recognized as financing expense or income in the consolidated statement of operations. The warrants were estimated by third party appraiser using the Black-Scholes option-pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet dates: The following are the data and assumptions used as of the balance sheet dates: March 31, Common stock price $ 0.6 Expected volatility 267.55 % Expected term (years) 3.43 Risk free rate 2.44 % Expected dividend yield 0 % Fair Market Value of Warrants $ 1 December 31, Common stock price 0.9585 Expected volatility 275.94 % Expected term (years) 3.68 Risk free rate 1.07 % Expected dividend yield 0 % Fair Market Value of Warrants $ 2 C. On April 6, 2021, the Company entered into a third Securities Purchase Agreement (“SPA”) with YAII PN, Ltd. (the “Investor”), pursuant to which the Investor agreed to provide the Company with a convertible loan in the aggregate amount of $150 and the Company agreed to issue convertible debentures and a warrant to the Investor. The loan will bear interest at an annual rate of ten percent (10%) and will be repayable after two years. The investment will be convertible at any time into shares of the Company’s Common Stock at a conversion price equal to the lower of (a) $3.46, or (b) 80% of the lowest the daily dollar volume-weighted average price for the Company’s Common Stock during the 10 trading days immediately preceding the conversion date. In accordance with ASC 815-15-25 the conversion feature was considered embedded derivative instrument and is to be recorded at its fair value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component fair value over the face loan amount. The conversion feature derivative liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations. The fair value of the convertible component was estimated by third party appraiser using the Monte Carlo Simulation Model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each of the issuance and balance sheet dates. The following are the data and assumptions used as of the balance sheet dates: March 31 , Common stock price $ 0.6 Expected volatility 162.97 % Expected term 1.02 Risk free rate 1.64 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 89 December 31 , Common stock price $ 0.9585 Expected volatility 275.94 % Expected term 1.27 Risk free rate 1.07 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 164 As part of the transaction, the Company issued to the Investor warrants to purchase an aggregate of 10,838 shares of Common Stock, at an exercise price equal to $3.46. The term of each warrant is five years from the issue date. Each warrant may be exercised by cash payment or through cashless exercise by the surrender of warrant shares having a value equal to the exercise price of the portion of the warrant being exercised. The warrants were estimated by third party appraiser using the Black-Scholes option-pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each of the issuance and balance sheet dates. The following are the data and assumptions used as of the balance sheet dates: March 31 , Common stock price $ 0.6 Expected volatility 267.6 % Expected term 4.02 Risk free rate 2.43 % Expected dividend yield 0 % Fair Market Value of Warrants $ 6 December 31 , Common stock price $ 0.9585 Expected volatility 275.94 % Expected term 4.27 Risk free rate 1.07 % Expected dividend yield 0 % Fair Market Value of Warrants $ 12 D. On June 7, 2021, Samsara Luggage, Inc. (the “Company”) entered into a fourth Securities Purchase Agreement (“SPA”) with the Investor, pursuant to which the Investor will invest an aggregate amount of $1,250 in three tranches, and the Company will issue convertible debentures and warrants to the Investor, in which each tranche is convertible into shares of the Company’s common stock, par value $0.0001 (the “Common Stock”). The first tranche in the principal amount of $500 was issued on June 7, 2021. The second tranche in the principal amount of $500 was issued on July 6, 2021 following the filing of a registration statement on Form S-1 (the “Registration Statement”) under the Securities Act of 1933, as amended, registering the Conversion Shares issuable upon conversion of the Convertible Debentures with the Securities and Exchange Commission (the “SEC”). The third tranche in the principal amount of $250 was issued on September 7, 2021 following the Registration Statement being declared effective by the SEC. On September 20, 2021, and pursuant to the SPA, YAII exercised its option to convert the Convertible Promissory Note principal in the amount of $100 into 47,887 shares of Common Stock of the Company. The fair market value of the shares was $130. On October 14, 2021, and pursuant to the SPA, YAII exercised its option to convert the Convertible Promissory Note principal in the amount of $150 and accrued interest of $1 into 109,018 shares of Common Stock of the Company. The fair market value of the shares was $211. As of December 31, 2021 the third tranche from September 7, 2021 was fully converted into shares of Common Stock. On November 3, 2021, and pursuant to the SPA, YAII exercised its option to convert the Convertible Promissory Note principal in the amount of $100 and accrued interest of $16 into 92,089 shares of Common Stock of the Company. The fair market value of the shares was $161. On December 20, 2021, and pursuant to the SPA, YAII exercised its option to convert the Convertible Promissory Note principal in the amount of $75 and accrued interest of $5 into 98,538 shares of Common Stock of the Company. The fair market value of the shares was $123. On March 1, 2022, and pursuant to the SPA, YAII exercised its option to convert the Convertible Promissory Note principal in the amount of $35 and accrued interest of $6 into 97,458 shares of Common Stock of the Company. The fair market value of the shares was $56. The Convertible Debentures bear interest at a rate of 10% per annum (15% on default) and have a maturity date of one (1) year. The Convertible Debentures provide a conversion right, in which any portion of the principal amount of the Convertible Debentures, together with any accrued but unpaid interest, may be converted into the Company’s Common Stock at a conversion price equal to 80% of the lowest volume weighted average price of the Company’s Common Stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment. The Convertible Debentures may not be converted into common stock to the extent such conversion would result in the Investor beneficially owning more than 9.99% of the Company’s outstanding Common Stock (the “Beneficial Ownership Limitation”); provided, however, that the Beneficial Ownership Limitation may be waived by the Investor upon not less than 65 days’ prior notice to the Company. The Convertible Debentures provide the Company with a redemption right, pursuant to which the Company, upon fifteen (15) business days’ prior notice to the Investor, may redeem, in whole or in part, outstanding principal and interest at a redemption price equal to the principal amount being redeemed plus a redemption premium equal to 5% of the outstanding principal amount being redeemed plus outstanding and accrued interest; however, the Investor shall have fifteen (15) business days after receipt of the Company’s redemption notice to elect to convert all or any portion of the Convertible Debentures, subject to the Beneficial Ownership Limitation. In connection with the Securities Purchase Agreement, the Company executed a registration rights agreement (the “Registration Rights Agreement”) pursuant to which it is required to file the Registration Statement with the SEC for the resale of the Conversion Shares. Pursuant to the Registration Rights Agreement, the Company is required to meet certain obligations with respect to, among other things, the timeliness of the filing and effectiveness of the Registration Statement. The Company is obligated to file the Registration Statement no later than 45 days after the First Closing Date and to have it declared effective by the SEC no later than 105 days after filing (the “Registration Obligations”). In accordance with ASC 815-15-25 the conversion feature was considered embedded derivative instrument and is to be recorded at its fair value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component fair value over the face loan amount. The conversion feature derivative liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations. The fair value of the convertible component was estimated by third party appraiser using the Monte Carlo Simulation Model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet dates: The following are the data and assumptions used as of the balance sheet dates: March 31 , Common stock price $ 0.6 Expected volatility 94.76 % Expected term 0.19 – 0.27 Risk free rate 0.39 – 0.55 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 319 December 31, Common stock price $ 0.9585 Expected volatility 86.8 – 87.57 % Expected term 0.43 – 0.51 Risk free rate 0.16 – 0.19 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 331 E. On December 14, 2021, Samsara Luggage, Inc. (the “Company”) entered into a fifth Securities Purchase Agreement (“SPA”) with the Investor, pursuant to which the Investor will invest an aggregate amount of $ 500, and the Company will issue convertible debentures to the Investor. The Convertible Debenture bears interest at a rate of 10% per annum (15% on default) and has a maturity date of one (1) year. The Convertible Debenture provides a conversion right, in which any portion of the principal amount of the Convertible Debenture, together with any accrued but unpaid interest, may be converted into the Company’s Common Stock at a conversion price equal to 80% of the lowest volume weighted average price of the Company’s Common Stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment. The Convertible Debenture may not be converted into common stock to the extent such conversion would result in the Investor beneficially owning more than 4.99% of the Company’s outstanding Common Stock; provided, however, that the Beneficial Ownership Limitation may be waived by the Investor upon not less than 65 days’ prior notice to the Company. The Convertible Debenture provides the Company with a redemption right, pursuant to which the Company, upon fifteen (15) business days’ prior notice to the Investor, may redeem, in whole or in part, outstanding principal and interest under the Convertible Debenture at a redemption price equal to the principal amount being redeemed plus a redemption premium equal to 5% of the outstanding principal amount being redeemed plus outstanding and accrued interest; however, the Investor shall have fifteen (15) business days after receipt of the Company’s redemption notice to elect to convert all or any portion of the Convertible Debenture, subject to the Beneficial Ownership Limitation. In accordance with ASC 815-15-25 the conversion feature was considered embedded derivative instrument and is to be recorded at its fair value as its fair value can be separated from the convertible loan and its conversion is independent of the underlying note value. The Company recorded finance expenses in respect of the convertible component in the convertible loan in the excess amount of the convertible component fair value over the face loan amount. The conversion feature derivative liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations. The following are the data and assumptions used as of the balance sheet date: March 31, Common stock price $ 0.6 Expected volatility 82.33 % Expected term 0.71 Risk free rate 1.3 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 204 December 31, Common stock price $ 0.9585 Expected volatility 205.2 % Expected term 0.95 Risk free rate 0.37 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 522 The following table presents the changes in fair value of the level 3 liabilities for the periods ended March 31, 2022 and December 31, 2021: Warrants Convertible (U.S. dollars in thousands) Outstanding at December 31, 2021 24 1,017 Settled upon debt conversion - (4 ) Changes in fair value (10 ) (402 ) Outstanding at March 31, 2022 14 611 Warrants Convertible (U.S. dollars in thousands) Outstanding at December 31, 2021 20 493 Fair value of issued level 3 liability 21 2,064 Changes in fair value (17 ) (1,540 ) Outstanding at December 31, 2021 24 1,017

Stockholders_ Equity

Stockholders’ Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 4 – STOCKHOLDERS’ EQUITY Common Stock On March 1, 2022, and pursuant to the SPA, YAII exercised its option to convert the Convertible Promissory Note principal in the amount of $35 and accrued interest of $6 into 97,458 shares of Common Stock of the Company. The fair market value of the shares was $56.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS Related party payable March 31, December 31, (U.S. dollars in thousands) Related party payable due to management fee 136 147 General and Administrative Expenses For the period ended For the period ended 2022 2021 (U.S. dollars in thousands) Management Fee 25 25 Research and development Expenses For the period ended For the period ended 2022 2021 (U.S. dollars in thousands) Consulting Fee 32 -

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 6 – SUBSEQUENT EVENTS Series A Preferred Stock On May 12, 2022, the Company established a series of redeemable convertible preferred stock (the “Series A Preferred Stock”), par value $0.0001 per share, pursuant to a Certificate of Designation, Preference and Rights of Series A Preferred Stock of the Company (the “Certificate of Designation”). Pursuant to the Certificate of Designation, the Company authorized 1,000,000 shares of the Series A Preferred Stock, which may be convertible into shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) at the option of the holders thereof at any time after the issuance of the Series A Preferred Stock, at a conversion price equal a Variable Conversion Price (the “Conversion Price”). The "Variable Conversion Price" means 80% multiplied by the Market Price (representing a discount rate of 20%). The “Market Price” means the average of the lowest two (2) Trading Prices (as defined below) for the Common Stock during the ten (10) Trading Day period ending on the latest complete trading day prior to the conversion date. The “Trading Price” means, for any security as of any date, the actual closing price on the OTCQB, OTCQX, Pink Sheets electronic quotation system or applicable trading market (the “OTC”). The Series A Preferred Stock will, with respect to dividend rights and rights upon liquidation, winding-up or dissolution, rank: (a) senior with respect to dividends and right of liquidation with the Company’s Common Stock and (b) junior with respect to dividends and right of liquidation to all existing and future indebtedness of the Company and existing and outstanding preferred stock of the Company. The Series A Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the shareholders are permitted to vote. Each share of Series A Preferred Stock will carry an annual dividend in the amount of six percent (6%) of the price per share of Series A Preferred Stock of $1.00 (the “Divided Rate”), which shall be cumulative, payable solely upon redemption, liquidation or conversion. Upon the occurrence of an event of default (as further defined further in the Certificate of Designation), the Dividend Rate shall automatically increase to fifteen percent (15%). Series A Preferred Stock Purchase Agreement On May 17, 2022, the Company entered into a Series A Preferred Stock Purchase Agreement (the “SPA”) with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, a Virginia limited liability company (the “Investor”) pursuant to which the Company issued and sold to the Investor 148,062 shares of Series A Preferred Stock for a purchase price of $128,750.00. Pursuant to the SPA, the Investor may convert all or a portion of the outstanding Series A Preferred Stock into shares of the Company’s Common Stock beginning on the date which is 180 days after the issuance date of the Series A Preferred Stock (the “Issuance Date”) into Common Stock; provided, however, that the Investor may not convert the Series A Preferred Stock to the extent that such conversion would result in beneficial ownership by the Investor and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. The Company will have the right, at the Company’s sole option, provided that an event of default has not occurred, to redeem all or any portion of the shares of Series A Preferred Stock, exercisable on not more than 3 Trading Days prior written notice to the holders of the Series A Preferred Stock, in full. If the Company redeems the shares of Series A Preferred Stock within 180 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 181st day and the 730th day after the issuance of the Series A Preferred Stock, then such redemption premium is 120%. After the 730th day following the Issuance Date, there shall be no further right of redemption. In connection with the Certificate of Designation, the Company agreed to cause its transfer agent to reserve four times the number of shares of Common Stock that would be issuable upon full conversion of the Series A Preferred Stock (assuming that the 4.99% limitation set forth in herein is not in effect) (based on the respective Conversion Price of the Series A Preferred Stock in effect from time to time).

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Unaudited Interim Financial Statements	Unaudited Interim Financial Statements The accompanying unaudited financial statements include the accounts of the Company, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the for three-months ended March 31, 2022. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2022. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates. Certain information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). The accompanying unaudited condensed financial statements should be read in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on April 11, 2022 (the “Annual Report”). For further information, reference is made to the financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“‘US GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As applicable to the financial statements, the most significant estimates and assumptions relate to the measurement of the convertible notes and Going Concern.
Derivative Liabilities and Fair Value of Financial Instruments	Derivative Liabilities and Fair Value of Financial Instruments Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt under ASC 470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815. Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Fair value of certain of the Company’s financial instruments including cash, accounts receivable, account payable, accrued expenses, notes payables, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments. Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of nonperformance, which includes, among other things, the Company’s credit risk. Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values. Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income. The Company records a debt discount related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the fair value of the conversion features. The debt discount will be accreted by recording additional non-cash gains and losses related to the change in fair values of derivative liabilities over the life of the convertible notes. The Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows: Balance as of March 31, 2022 Level 1 Level 2 Level 3 Total (U.S. dollars in thousands) Liabilities: Fair Value of convertible component in convertible loan, net of discounts and debt issue costs - - 611 611 Fair value of warrants issued in convertible loan - - 14 14 Total liabilities - - 625 625 Balance as of December 31, 2021 Level 1 Level 2 Level 3 Total (U.S. dollars in thousands) Liabilities: Fair Value of convertible component in convertible loan, net of discounts and debt issue costs - - 1,017 1,017 Fair value of warrants issued in convertible loan - - 24 24 Total liabilities - - 1,041 1,041
Reclassification	Reclassification Certain comparative figures have been reclassified to conform to current period presentation.
Recent accounting pronouncements	Recent accounting pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies and Basis of Presentation (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Schedule of financial assets and liabilities that are measured at fair value on a recurring basis	Balance as of March 31, 2022 Level 1 Level 2 Level 3 Total (U.S. dollars in thousands) Liabilities: Fair Value of convertible component in convertible loan, net of discounts and debt issue costs - - 611 611 Fair value of warrants issued in convertible loan - - 14 14 Total liabilities - - 625 625 Balance as of December 31, 2021 Level 1 Level 2 Level 3 Total (U.S. dollars in thousands) Liabilities: Fair Value of convertible component in convertible loan, net of discounts and debt issue costs - - 1,017 1,017 Fair value of warrants issued in convertible loan - - 24 24 Total liabilities - - 1,041 1,041

Convertible Notes (Tables)

Convertible Notes (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of the fair value of the derivative at each balance sheet	March 31, Common stock price $ 0.6 Expected volatility 270.18 % Expected term 2.18 years Risk free rate 2.31 % Expected dividend yield 0 % Fair Market Value of Warrants $ 6 December 31, Common stock price 0.9585 Expected volatility 275.94 % Expected term 2.43 years Risk free rate 0.83 % Expected dividend yield 0 % Fair Market Value of Warrants $ 10 March 31, Common stock price $ 0.6 Expected volatility 267.55 % Expected term (years) 3.43 Risk free rate 2.44 % Expected dividend yield 0 % Fair Market Value of Warrants $ 1 December 31, Common stock price 0.9585 Expected volatility 275.94 % Expected term (years) 3.68 Risk free rate 1.07 % Expected dividend yield 0 % Fair Market Value of Warrants $ 2 March 31 , Common stock price $ 0.6 Expected volatility 162.97 % Expected term 1.02 Risk free rate 1.64 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 89 December 31 , Common stock price $ 0.9585 Expected volatility 275.94 % Expected term 1.27 Risk free rate 1.07 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 164 March 31 , Common stock price $ 0.6 Expected volatility 267.6 % Expected term 4.02 Risk free rate 2.43 % Expected dividend yield 0 % Fair Market Value of Warrants $ 6 December 31 , Common stock price $ 0.9585 Expected volatility 275.94 % Expected term 4.27 Risk free rate 1.07 % Expected dividend yield 0 % Fair Market Value of Warrants $ 12 March 31 , Common stock price $ 0.6 Expected volatility 94.76 % Expected term 0.19 – 0.27 Risk free rate 0.39 – 0.55 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 319 December 31, Common stock price $ 0.9585 Expected volatility 86.8 – 87.57 % Expected term 0.43 – 0.51 Risk free rate 0.16 – 0.19 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 331 March 31, Common stock price $ 0.6 Expected volatility 82.33 % Expected term 0.71 Risk free rate 1.3 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 204 December 31, Common stock price $ 0.9585 Expected volatility 205.2 % Expected term 0.95 Risk free rate 0.37 % Expected dividend yield 0 % Fair Market Value of Convertible component $ 522
Schedule of changes in fair value of the level 3 liabilities	Warrants Convertible (U.S. dollars in thousands) Outstanding at December 31, 2021 24 1,017 Settled upon debt conversion - (4 ) Changes in fair value (10 ) (402 ) Outstanding at March 31, 2022 14 611 Warrants Convertible (U.S. dollars in thousands) Outstanding at December 31, 2021 20 493 Fair value of issued level 3 liability 21 2,064 Changes in fair value (17 ) (1,540 ) Outstanding at December 31, 2021 24 1,017

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Schedule of related party transactions	March 31, December 31, (U.S. dollars in thousands) Related party payable due to management fee 136 147 For the period ended For the period ended 2022 2021 (U.S. dollars in thousands) Management Fee 25 25 For the period ended For the period ended 2022 2021 (U.S. dollars in thousands) Consulting Fee 32 -

Organization and Description _2

Organization and Description of Business (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Organization and Description of Business [Abstract]
Cash and cash equivalents	$ 349
Deficit of working capital	758
Stockholders’ deficiency	755
Accumulated deficit	$ 10,483

Summary of Significant Accoun_3

Summary of Significant Accounting Policies and Basis of Presentation (Details) - Schedule of financial assets and liabilities that are measured at fair value on a recurring basis - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Liabilities:
Fair Value of convertible component in convertible loan, net of discounts and debt issue costs	$ 611	$ 1,017
Fair value of warrants issued in convertible loan	14	24
Total liabilities	625	1,041
Level 1 [Member]
Liabilities:
Fair Value of convertible component in convertible loan, net of discounts and debt issue costs
Fair value of warrants issued in convertible loan
Total liabilities
Level 2 [Member]
Liabilities:
Fair Value of convertible component in convertible loan, net of discounts and debt issue costs
Fair value of warrants issued in convertible loan
Total liabilities
Level 3 [Member]
Liabilities:
Fair Value of convertible component in convertible loan, net of discounts and debt issue costs	611	1,017
Fair value of warrants issued in convertible loan	14	24
Total liabilities	$ 625	$ 1,041

Convertible Notes (Details)

Convertible Notes (Details) - USD ($)	Mar. 01, 2022	Dec. 14, 2021	Nov. 03, 2021	Oct. 14, 2021	Jun. 07, 2021	Apr. 06, 2021	Sep. 03, 2020	Dec. 20, 2021	Mar. 31, 2022	Sep. 20, 2021	Jun. 05, 2019
Convertible Notes (Details) [Line Items]
Exercisable term									5 years
Warrants to purchase shares of common stock (in Shares)									2,619
Conversion price (in Dollars per share)									$ 21
Conversion price, percentage									80.00%
Interest rate									10.00%
Default interest rate		15.00%							15.00%
Maturity term									1 year
Outstanding common stock, percentage									9.99%
Outstanding principal amount, percentage									5.00%
Common Stock [Member]
Convertible Notes (Details) [Line Items]
Common stock, par value (in Dollars per share)					$ 0.0001
Securities Purchase Agreement [Member]
Convertible Notes (Details) [Line Items]
Convertible debt											$ 1,100,000
Debt instrument, description									The first tranche of the convertible debentures in the amount of $200,000 was provided upon execution of the SPA. The second tranche in the amount of $300,000 was provided on October 23, 2019 upon the Company filing of a Registration Statement on Form S-4 in connection with the Merger with Samsara Delaware. The third tranche in the amount of $600,000 was provided on November 18, 2019 upon consummation of the Merger with Samsara Delaware and the fulfillment of all conditions required for the Merger. The Company incurred issuance cost of $100,000 with connection to those convertible debentures.
Exercise price (in Dollars per share)						$ 3.46
Description of convertible notes						The loan will bear interest at an annual rate of ten percent (10%) and will be repayable after two years.	the Investor, pursuant to which the Investor will invest an aggregate amount of $220 in two tranches, and the Company will issue convertible debentures and warrants to the Investor. The first tranche of the convertible debentures in the amount of $150 was provided upon execution of the SPA. The second tranche in the amount of $70 was provided on October 7, 2020. Each tranche of the loan bears interest at an annual rate of ten percent (10%). Each tranche of the investment bears interest at an annual rate of ten percent (10%) and will be repayable after two years. Each tranche of the investment will be convertible at any time into shares of the Company’s Common Stock at a conversion price equal to the lower of (a) $0.003 per share, or (b) 80% of the lowest the daily dollar volume-weighted average price for the Company’s Common Stock during the 10 trading days immediately preceding the conversion date.
Principal amount	$ 35,000	$ 500,000	$ 100,000	$ 150,000		$ 150,000		$ 75,000
Conversion price, percentage		80.00%				80.00%
Accrued interest	$ 6,000		$ 16,000	$ 1,000				$ 5,000
Issuance of common stock (in Shares)	97,458		92,089	109,018				98,538
Aggregate amount					$ 1,250,000
Fair value market	$ 56,000		$ 161,000	$ 211,000				$ 123,000
Interest rate		10.00%
Maturity term		1 year
Outstanding common stock, percentage		4.99%
Outstanding principal amount, percentage		5.00%
Investor Warrants [Member]
Convertible Notes (Details) [Line Items]
Issuance of common stock (in Shares)									5
Convertible Promissory Note [Member]
Convertible Notes (Details) [Line Items]
Warrants to purchase (in Shares)									13,095
Exercise price (in Dollars per share)									$ 21
Exercisable term									5 years
Principal amount	35								$ 10,838,000
Accrued interest	6								$ 3,460
Issuance of common stock (in Shares)										47,887
Fair value market	$ 56
Convertible Debt [Member]
Convertible Notes (Details) [Line Items]
Principal amount										$ 100,000
Convertible terms, description					The first tranche in the principal amount of $500 was issued on June 7, 2021. The second tranche in the principal amount of $500 was issued on July 6, 2021 following the filing of a registration statement on Form S-1 (the “Registration Statement”) under the Securities Act of 1933, as amended, registering the Conversion Shares issuable upon conversion of the Convertible Debentures with the Securities and Exchange Commission (the “SEC”). The third tranche in the principal amount of $250 was  issued on September 7, 2021 following the Registration Statement being declared effective by the SEC.
Fair value market										$ 130,000

Convertible Notes (Details) - S

Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Common stock price (in Dollars per share)	$ 0.6	$ 0.9585
Expected volatility	267.60%	275.94%
Expected term (years)	4 years 7 days	4 years 3 months 7 days
Risk free rate	2.43%	1.07%
Expected dividend yield	0.00%	0.00%
Fair Market Value of Warrants (in Dollars)	$ 6	$ 12
June 5, 2019 [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Common stock price (in Dollars per share)	$ 0.6	$ 0.9585
Expected volatility	270.18%	275.94%
Expected term (years)	2 years 2 months 4 days	2 years 5 months 4 days
Risk free rate	2.31%	0.83%
Expected dividend yield	0.00%	0.00%
Fair Market Value of Warrants (in Dollars)	$ 6	$ 10
September 3, 2020 [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Common stock price (in Dollars per share)	$ 0.6	$ 0.9585
Expected volatility	267.55%	275.94%
Expected term (years)	3 years 5 months 4 days	3 years 8 months 4 days
Risk free rate	2.44%	1.07%
Expected dividend yield	0.00%	0.00%
Fair Market Value of Warrants (in Dollars)	$ 1	$ 2
April 6, 2021 [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Common stock price (in Dollars per share)	$ 0.6	$ 0.9585
Expected volatility	162.97%	275.94%
Expected term (years)	1 year 7 days	1 year 3 months 7 days
Risk free rate	1.64%	1.07%
Expected dividend yield	0.00%	0.00%
Fair Market Value of Convertible component (in Dollars)	$ 89	$ 164
June 7, 2021 [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Common stock price (in Dollars per share)	$ 0.6	$ 0.9585
Expected volatility	94.76%
Expected dividend yield	0.00%	0.00%
Fair Market Value of Convertible component (in Dollars)	$ 319	$ 331
June 7, 2021 [Member] | Minimum [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Expected volatility		86.80%
Expected term (years)	2 months 8 days	5 months 4 days
Risk free rate	0.39%	0.16%
June 7, 2021 [Member] | Maximum [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Expected volatility		87.57%
Expected term (years)	3 months 7 days	6 months 3 days
Risk free rate	0.55%	0.19%
December 14, 2021 [Member]
Convertible Notes (Details) - Schedule of the fair value of the derivative at each balance sheet [Line Items]
Common stock price (in Dollars per share)	$ 0.6	$ 0.9585
Expected volatility	82.33%	205.20%
Expected term (years)	8 months 15 days	11 months 12 days
Risk free rate	1.30%	0.37%
Expected dividend yield	0.00%	0.00%
Fair Market Value of Convertible component (in Dollars)	$ 204	$ 522

Convertible Notes (Details) -_2

Convertible Notes (Details) - Schedule of changes in fair value of the level 3 liabilities - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Warrants [Member]
Convertible Notes (Details) - Schedule of changes in fair value of the level 3 liabilities [Line Items]
Outstanding, beginning balance	$ 24	$ 20
Fair value of issued level 3 liability		21
Settled upon debt conversion
Changes in fair value	(10)	(17)
Outstanding, ending balance	14	24
Convertible Component [Member]
Convertible Notes (Details) - Schedule of changes in fair value of the level 3 liabilities [Line Items]
Outstanding, beginning balance	1,017	493
Fair value of issued level 3 liability		2,064
Settled upon debt conversion	(4)
Changes in fair value	(402)	(1,540)
Outstanding, ending balance	$ 611	$ 1,017

Stockholders_ Equity (Details)

Stockholders’ Equity (Details) - Convertible Promissory Note [Member] - USD ($)	Mar. 01, 2022	Mar. 31, 2022
Stockholders’ Equity (Details) [Line Items]
Principal amount	$ 35	$ 10,838,000
Accrued interest	$ 6	$ 3,460
Shares of common stock (in Shares)	97,458
Fair market value	$ 56

Related Party Transactions (Det

Related Party Transactions (Details) - Schedule of related party transactions - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Schedule of related party transactions [Abstract]
Related party payable due to management fee	$ 136		$ 147
Management Fee	25	$ 25
Consulting Fee	$ 32

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	May 17, 2022	May 12, 2022
Subsequent Events (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001
Variable conversion price percentage		80.00%
Discount rate		20.00%
Dividend rate percentage		15.00%
Subsequent event, description	The Company will have the right, at the Company’s sole option, provided that an event of default has not occurred, to redeem all or any portion of the shares of Series A Preferred Stock, exercisable on not more than 3 Trading Days prior written notice to the holders of the Series A Preferred Stock, in full. If the Company redeems the shares of Series A Preferred Stock within 180 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 181st day and the 730th day after the issuance of the Series A Preferred Stock, then such redemption premium is 120%. After the 730th day following the Issuance Date, there shall be no further right of redemption.
Series A Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Series of redeemable convertible preferred stock (in Dollars per share)		$ 0.0001
Authorized shares (in Shares)		1,000,000
Dividend rate percentage		6.00%
Price per share (in Dollars per share)		$ 1
Investor shares (in Shares)	148,062
Purchase price (in Dollars)	$ 128,750,000
Ownership percentage	4.99%
Conversion percentage	4.99%